Website profile

European Medical Journal

emjreviews.com
All articles Clear site filter
  • 207articles · 30d
  • 1+ day agolatest article
  • Aug 16, 2026earliest in window
  • 91%with images
  • 312avg words
articles per day
Covers
People
Places
Organizations
Categories
  • Medical 207
  • Health & Wellness 200
  • Health 193
  • Science & Technology 11
  • Economy, Business & Finance 3
  • Beauty & Fitness 3
  • Business & Industrial 2
  • Food & Drink 2
Bylines

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

European Medical Journal
emjreviews.com > emj-gold > news > abbvie-drug-meets-phase-3-goal-in-menstrual-migraine

AbbVie drug meets phase 3 goal in menstrual migraine

2+ day, 23+ hour ago   (362+ words) AbbVie’s atogepant has met the primary endpoint of the phase 3 LUNA trial, which tested the drug as a preventive treatment for menstrual migraine. In the phase 3 LUNA trial, atogepant reduced migraine days during the perimenstrual period by an average of…...

European Medical Journal
emjreviews.com > oncology > news > new-target-identified-to-limit-triple-negative-breast-cancer-spread

New Target Identified to Limit Triple-Negative Breast Cancer Spread

2+ week, 5+ day ago   (479+ words) A MOLECULAR network that helps drive the spread of triple-negative breast cancer (TNBC) could provide a new target for treatment, new research shows. According to a study published in EMBO Molecular Medicine, researchers identified low levels of the microRNA miR…...